|
1. |
Amniotic Fluid Matrix Metalloproteinase‐9 Levels in Women With Preterm Labor and Suspected Intra‐amniotic Infection |
|
Obstetrics & Gynecology,
Volume 94,
Issue 1,
1999,
Page 1-6
GREGORY LOCKSMITH,
PENNY CLARK,
PATRICK DUFF,
GREGORY SCHULTZ,
Preview
|
PDF (198KB)
|
|
摘要:
ObjectiveTo determine the accuracy of amniotic fluid (AF) matrix metalloproteinase-9 measurements for diagnosing intra-amniotic infection in women with preterm labor.MethodsWe performed amniocenteses in 44 women between 22 and 35 weeks' gestation who presented to our center with preterm labor and clinical suspicion of intra-amniotic infection. Each sample was analyzed by glucose measurement, Gram stain, and culture for aerobes, anaerobes, and mycoplasmas. We tested the AF for matrix metalloproteinase-9 using gelatin zymography and a commercial enzyme-linked immunosorbent assay (ELISA) system. We calculated accuracy and confidence intervals (CIs) for AF matrix metalloproteinase-9, glucose, and Gram stain for diagnosing intra-amniotic infection, using culture as the criterion standard.ResultsAll patients who had matrix metalloproteinase-9 detectable by ELISA also demonstrated matrix metalloproteinase-9 by zymography. Six cases of intra-amniotic infection were confirmed by culture (prevalence 14%). The performance statistics of AF matrix metalloproteinase-9 for diagnosing intra-amniotic infection were: sensitivity 83% (95% CI 53, 99), specificity 95% (95% CI 88, 99), positive predictive value 71% (95% CI 37, 99), and negative predictive value 97% (95% CI 92, 99). Two women had false-positive results; one had gram-negative rods on the AF Gram stain and developed clinical signs and symptoms of chorioamnionitis several hours after amniocentesis and the other had a purulent vaginal discharge and an AF glucose level less than 15 mg/dL. Both delivered within 24 hours of amniocentesis.ConclusionMeasuring matrix metalloproteinase-9 in the AF appeared to be reliable for diagnosing intra-amniotic infection. An elevated matrix metalloproteinase-9 concentration in the AF at a preterm gestational age may portend imminent delivery regardless of microbiologic confirmation of intra-amniotic infection.
ISSN:0029-7844
出版商:OVID
年代:1999
数据来源: OVID
|
2. |
Elevated Amniotic Fluid Nucleosome Levels in Women With Intra‐amniotic Infection |
|
Obstetrics & Gynecology,
Volume 94,
Issue 1,
1999,
Page 7-10
LI-CHENG LU,
CHAUR-DONG HSU,
Preview
|
PDF (147KB)
|
|
摘要:
ObjectiveTo compare amniotic fluid (AF) soluble nucleo-some levels in pregnant women with and without intra-amniotic infection.MethodsAmniocentesis was performed in 74 pregnant women with preterm contractions, labor, or premature rupture of membranes. Intra-amniotic infection was defined as a positive AF culture. Amniotic fluid tests for Gram stain, glucose, neutrophils, creatinine, pH, and specific gravity were performed. Amniotic fluid soluble nucleosome levels were determined by enzyme-linked immunosorbent assay and were normalized by AF creatinine levels.ResultsTwenty-eight patients had intra-amniotic infection and 46 did not. Amniotic fluid soluble nucleosome levels were significantly higher in pregnant women with intra-amniotic infection than in those without infection (48.1±21.3 compared with 0.0 ± 0.0 U/mg creatinine;P= .005). The AF nucleosome levels were positively correlated with AF neutrophil counts and negatively correlated with AF glucose concentrations.ConclusionOur data indicate that elevated AF nucleo-some levels are associated with intra-amniotic infection and may have potential as a clinical marker to detect intra-amniotic infection.
ISSN:0029-7844
出版商:OVID
年代:1999
数据来源: OVID
|
3. |
Prostaglandin E2Cervical Ripening Without Subsequent Induction of Labor |
|
Obstetrics & Gynecology,
Volume 94,
Issue 1,
1999,
Page 11-14
DAVID MCKENNA,
STEPHANIE COSTA,
PHILIP SAMUELS,
Preview
|
PDF (142KB)
|
|
摘要:
ObjectiveTo determine whether outpatient administration of intracervical prostaglandin (PG) gel decreases the E2interval to delivery and duration of labor.MethodsA randomized, double-blind, placebo-controlled trial compared the intracervical placement of 0.5 mg PGE2gel with placebo in 61 pregnant women at 38 weeks' or greater gestation with Bishop scores less than 9. Transvaginal cervical length, fetal fibronectin, and Bishop score were assessed before gel placement. Subjects were then allowed to go into spontaneous labor unless an indication for induction developed.ResultsThirty women were assigned to PGE2and 31 to placebo. There were no significant demographic differences between the groups and there were no differences in cervical length, fetal fibronectin status, or Bishop scores. Fifteen women in the PGE2group and five in the placebo group went into labor and delivered within the first 2 days after gel placement (P= .007). The median interval to delivery was significantly shorter in the PGE2group, at 2.5 days, compared with placebo, at 7 days (P= .02). Nulliparas in the PGE2group had a median interval to delivery of 2 days, compared with 7 days for nulliparas receiving placebo (P= .03). Active phases of labor were significantly shorter in the PGE2group and for women with a negative fetal fibronectin test who received PGE2.ConclusionOutpatient administration of intracervical gel shortened intervals to delivery and shortened PGE2labor.
ISSN:0029-7844
出版商:OVID
年代:1999
数据来源: OVID
|
4. |
Pregnancy in Women With Systemic Sclerosis |
|
Obstetrics & Gynecology,
Volume 94,
Issue 1,
1999,
Page 15-20
VIRGINIA STEEN,
Preview
|
PDF (146KB)
|
|
摘要:
ObjectiveTo determine pregnancy outcomes in women with systemic sclerosis.MethodsWomen of childbearing age with systemic sclerosis seen at the University of Pittsburgh between 1987 and 1996 were observed prospectively. Pregnancy outcomes included abortion, miscarriage, preterm and term birth, and perinatal death. Complications of pregnancy and scleroderma were determined during and after pregnancy.ResultsFifty-nine women with systemic sclerosis had 91 pregnancies during the 10-year period. No increase in the frequency of miscarriage was found, except in those with long-standing diffuse scleroderma. Preterm births occurred in 29% of pregnancies, and all but one of the infants survived. Symptoms related to scleroderma, particularly Raynaud phenomenon, improved during pregnancy, but esophageal reflux became worse. After pregnancy, some women with diffuse scleroderma had increased skin thickening. There were three cases of renal crisis during pregnancy, all in women with early diffuse scleroderma. Four women had five healthy infants while taking angiotensin-converting-enzyme inhibitors.ConclusionWomen with systemic sclerosis can safely have healthy pregnancies. Those with early diffuse scleroderma should wait until their disease stabilizes before becoming pregnant to decrease the risk of renal crisis. High-risk pregnancy management should be standard for all scleroderma pregnancies because of the high frequency of premature births.
ISSN:0029-7844
出版商:OVID
年代:1999
数据来源: OVID
|
5. |
Anal Sphincter Tears at Vaginal DeliveryRisk Factors and Clinical Outcome of Primary Repair |
|
Obstetrics & Gynecology,
Volume 94,
Issue 1,
1999,
Page 21-28
JAN ZETTERSTRÖM,
ANNIKA LÓPEZ,
BO ANZÉN,
MARGARETA NORMAN,
BO HOLMSTRÖM,
ANDERS MELLGREN,
Preview
|
PDF (181KB)
|
|
摘要:
ObjectiveTo determine risk factors for obstetric anal sphincter tears and to evaluate symptomatic outcome of primary repair.MethodsObstetric-procedure, maternal, and fetal data were registered in 845 consecutive vaginally delivered women. Risk factors for anal sphincter tears were calculated by multiple logistic regression. All 808 Swedish-speaking women who delivered vaginally were included in a questionnaire study regarding anal incontinence in relation to the delivery. Questionnaires were distributed within the first few days postpartum, and at 5 and 9 months postpartum.ResultsSix percent of the women had a clinically detected sphincter tear at delivery. Sphincter tears were associated with nulliparity (odds ratio [OR] 9.8, 95% confidence interval [CI] 3.6, 26.2), postmaturity (OR 2.5, 95% CI 1.0, 6.2), fundal pressure (OR 4.6 95% CI 2.3, 7.9), midline episiotomy (OR 5.5 95% CI 1.4, 18.7), and fetal weight in intervals of 250 g (OR 1.3 95% CI 1.1, 1.6). Fifty-four percent of women with repaired sphincter tears suffered from fecal or gas incontinence or both at 5 months and 41% at 9 months. Most of the symptoms were infrequent and mild.ConclusionSeveral risk factors for sphincter tear were identified. Sphincter tear at vaginal delivery is a serious complication, and it is frequently associated with anal incontinence. Special attention should be directed toward risk factors for this complication. Symptoms of anal incontinence should explicitly be sought at follow-up after delivery.
ISSN:0029-7844
出版商:OVID
年代:1999
数据来源: OVID
|
6. |
Cost‐Effectiveness of Estimating Gestational Age by Ultrasonography in Down Syndrome Screening |
|
Obstetrics & Gynecology,
Volume 94,
Issue 1,
1999,
Page 29-33
PETER BENN,
JOHN RODIS,
TRYFON BEAZOGLOU,
Preview
|
PDF (146KB)
|
|
摘要:
ObjectiveTo quantify the financial benefits of using ultrasound estimation of gestational age in maternal serum screening for Down syndrome.MethodsMaternal age-specific sensitivity and false-positive rates for Down syndrome were derived for the triple test (alpha-fetoprotein, hCG, and unconjugated estriol) using gestational age based on ultrasound dating and also time from the last menstrual period (LMP). These rates were entered into a formula to determine the societal financial net benefit of Down syndrome screening. The average per-case net benefits of ultrasound- and LMP-dated pregnancies were then compared. Average net benefits were also calculated separately with ultrasound versus LMP dating for triple tests referred to our laboratory, and the additional costs associated with any post-test ultrasound scans, repeat testing, or recalculations were estimated.ResultsThe use of ultrasound dating resulted in higher detection rates for Down syndrome and lower false-positive rates, which translated into an average per-case savings to society of $33.54. For women referred to our program with LMP dating, there was an average reduction of $31.60 in net benefits, plus added costs of $14.39 attributable to extra ultrasound, repeat testing, and recalculation.ConclusionWhen ultrasound dating is available before serum screening, it should be used preferentially to establish Down syndrome risk. Routine first-trimester ultrasound examination can be justified for women with a known LMP if the cost of the ultrasound examination is less than $46.
ISSN:0029-7844
出版商:OVID
年代:1999
数据来源: OVID
|
7. |
Rapid Testing and Zidovudine Treatment to Prevent Vertical Transmission of Human Immunodeficiency Virus in Unregistered ParturientsA Cost‐Effectiveness Analysis |
|
Obstetrics & Gynecology,
Volume 94,
Issue 1,
1999,
Page 34-40
JEFFREY STRINGER,
DWIGHT ROUSE,
Preview
|
PDF (182KB)
|
|
摘要:
ObjectiveTo assess the potential effectiveness and costs of a program to prevent vertical transmission of human immunodeficiency virus (HIV) in parturients without prenatal care.MethodsA decision-analysis model was constructed to compare three management strategies for unregistered women presenting in labor: 1) the current standard of treating no one; 2) HIV testing with a rapid antibody assay, followed by zidovudine treatment according to AIDS Clinical Trial Group Protocol 076 if seropositive; and 3) treating all women without rapid testing. Cost and probability data were obtained from a literature review and local estimates. Sensitivity analyses were performed for pertinent uncertainties.ResultsUnder baseline assumptions (5% HIV prevalence, treatment efficacy of an 18% reduction in transmission rate, and lifetime cost of pediatric HIV $103,708), giving no treatment resulted in 1275 infected infants per 100,000 mother-infant pairs. The rapid-test strategy prevented 183 cases of infant HIV infection and resulted in a net savings to the medical system of $57,997 per case averted. The treat-all strategy prevented an additional 46 cases per 100,000 mother-infant pairs, but at a cost of $342,068 per additional case averted. With other estimates at baseline, rapid testing was cost-saving when the HIV prevalence exceeded 0.97%, the treatment efficacy exceeded a 5.8% reduction in the transmission rate, and the lifetime cost of pediatric HIV infection exceeded $33,625.ConclusionRapid HIV testing of unregistered parturients followed by zidovudine treatment if seropositive would be cost saving to the medical system.
ISSN:0029-7844
出版商:OVID
年代:1999
数据来源: OVID
|
8. |
Selection of Delivery Method in Pregnancies Complicated by Autoimmune ThrombocytopeniaA Decision Analysis |
|
Obstetrics & Gynecology,
Volume 94,
Issue 1,
1999,
Page 41-47
DAVID STAMILIO,
GEORGE MACONES,
Preview
|
PDF (169KB)
|
|
摘要:
ObjectiveTo compare three common strategies for selecting delivery methods in term pregnancies complicated by immune thrombocytopenia by contrasting their effects on the number of severely thrombocytopenic neonates delivered vaginally and total cesarean rates.MethodsWe used decision analysis to compare three strategies to select delivery method in women with autoimmune thrombocytopenia, funipuncture at term, intrapartum fetal scalp platelet sampling with delivery mode decisions based on platelet count in the first two strategies, and no testing of fetal platelets with delivery mode determined by standard obstetric criteria. We assumed that the goal of each strategy was to minimize the number of severely thrombocytopenic neonates delivered vaginally while maintaining an acceptable cesarean rate. Severe thrombocytopenia was defined as under 50,000 platelets per μL. Probabilities with ranges (used in sensitivity analyses) were derived from the medical literature.ResultsOf the two testing strategies, funipuncture was clearly preferable. Funipuncture resulted in zero cases of severely thrombocytopenic neonates delivered vaginally (as did scalp sampling), with a lower overall cesarean rate compared with fetal scalp sampling (36.6% versus 69.1%). Compared with the no-testing strategy, the funipuncture strategy reduced the number of severely thrombocytopenic neonates delivered vaginally (0 versus 82 per 1000) with a modest increase in the cesarean rate (1.9 cesareans to prevent vaginal delivery of one severely thrombocytopenic neonate).ConclusionFetal scalp sampling should be abandoned in favor of funipuncture when testing for thrombocytopenia.
ISSN:0029-7844
出版商:OVID
年代:1999
数据来源: OVID
|
9. |
Thoracic‐Fluid Conductivity in Peripartum Women With Pulmonary Edema |
|
Obstetrics & Gynecology,
Volume 94,
Issue 1,
1999,
Page 48-51
ROGER NEWMAN,
HAROLD PIERRE,
JAMES SCARDO,
Preview
|
PDF (173KB)
|
|
摘要:
ObjectiveTo measure the level of thoracic-fluid conductivity associated with pulmonary edema in peripartum women by noninvasive thoracic electrical bioimpedance.MethodsBetween March 1994 and August 1996, 134 women were selected for thoracic electrical bioimpedance monitoring. Among them, 12 had pulmonary edema, 33 had severe preeclampsia, 17 had mild preeclampsia, and 72 were in uncomplicated early labor. Each subject's highest thoracic-fluid conductivity measurement was related to her clinical presentation. The Kruskal-Wallis one-way analysis of variance was used to compare groups' means. A receiver operating characteristic curve was used to identify thoracic-fluid conductivity values associated with pulmonary edema.ResultsPulmonary edema was associated with severe preeclampsia in ten cases, urosepsis in one case, and postoperative volume overload in one case. Other than gestational age, there were no significant differences in maternal demographics between groups. Thoracic-fluid conductivity values in women with pulmonary edema (80.6 ± 18.3 kohm−1) were significantly higher than those in women with severe preeclampsia (62.8 ± 16.3 kohm−1), mild preeclampsia (53.3 ± 11.2 kohm−1), or early labor (41.3 ± 6.7 kohm−1). Thoracic-fluid conductivity of at least 65 kohm−1best identified pulmonary edema (sensitivity 83.3%; specificity 86.9%; positive predictive value 38.5%; negative predictive value 98.1%).ConclusionPreeclampsia was associated with increased thoracic-fluid conductivity stratified between mild and severe disease. Thoracic-fluid conductivity of at least 65 kohm−1was strongly associated with peripartum pulmonary edema. Women with values above 65 kohm−1might be candidates for medical intervention even without overt clinical symptoms.
ISSN:0029-7844
出版商:OVID
年代:1999
数据来源: OVID
|
10. |
Bone Mineral Changes During and After Lactation |
|
Obstetrics & Gynecology,
Volume 94,
Issue 1,
1999,
Page 52-56
FRANCO POLATTI,
EZIO CAPUZZO,
FRANCO VIAZZO,
ROSSELLA COLLEONI,
CATHERINE KLERSY,
Preview
|
PDF (144KB)
|
|
摘要:
ObjectiveTo investigate variations in bone mineral density during lactation and throughout the 12 months after scheduled cessation of lactation in relation to the resumption of ovarian function.MethodsThree hundred eight mothers who decided to lactate were scheduled to fully breast-feed for 6 months, followed by a 1-month weaning period, and then suppress lactation with cabergoline. Their bone mineral density variations were compared with those of a control group of nonlactating mothers during the first 18 months postpartum. Half the lactating women were given daily oral calcium supplements of 1 g in an open design.ResultsThere was a significant progressive decrease in bone mineral density in lactating women over the first 6 months, followed by recovery of bone mass up to levels that at 18 months were higher than baseline. In nonlactating women, bone mineral density increased progressively after delivery, and at 18 months postpartum had increased by 1.1–1.9% compared with baseline. Compared with lactating women who resumed menstruation within 5 months of delivery, breast-feeding mothers with longer amenorrhea initially lost more bone, but they also gained significantly more bone after resumption of menses, so there were no differences at 18 months postpartum. Oral calcium supplementation decreased bone loss, but had only a transient effect.ConclusionA scheduled lactation period of 6 months, followed by a 1-month weaning period, allowed bone mineral density to reach higher values compared with early postpartum, regardless of calcium supplementation and duration of postpartum amenorrhea.
ISSN:0029-7844
出版商:OVID
年代:1999
数据来源: OVID
|
|